A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.adw2286
Affiliations:
2
Authors:
14
Go to article
Institutions Authors Share
University of Nebraska Medical Center (UNMC), United States of America (USA)
13.000000
13.000000
 0.93
Fred and Pamela Buffett Cancer Center, United States of America (USA)
1.000000
 0.07
Interested in Clinical Sciences?